Back to search results
NCT05587244

G7 Freedom Constrained Vivacit-E Liners

Enrolling by Invitation
NAAges 18–80InterventionalTreatment
Zimmer Biomet
~202 participants
Updated 2025-10-20 on ClinicalTrials.gov
What's tested:Total Hip Arthroplasty with G7 Freedom Constrained Vivacit-E Liners

At a glance

Recruiting sites
0 of 10 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Survival of the study device
Measured over 10 years

Conditions

Osteoarthritis, Hip
Rheumatoid Arthritis
Non-Union Fracture
Trochanteric Fractures
Femoral Neck Fractures
Avascular Necrosis
Dislocation, Hip

Explore related trials

Avascular NecrosisFracture of neck of femurFracture, ununitedHip DislocationOsteoarthritisRheumatoid ArthritisTrochanteric Fractures

NCT05587244

Where you'd take part

This study runs at 10 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Jersey City Medical Center, Inc

    Livingston, New Jerseyno site contact published

  • Medical City Plano

    Plano, Texasno site contact published

  • The Ohio State University

    Columbus, Ohiono site contact published

  • The University of Texas Health Science Center of Houston

    Houston, Texasno site contact published

  • TOA Research Foundation

    Knoxville, Tennesseeno site contact published

  • University of Alabama at Birmingham

    Birmingham, Alabamano site contact published

  • University of Florida Board of Trustees

    Gainesville, Floridano site contact published

  • University of Southern California

    Los Angeles, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Hillary Overholser · STUDY_DIRECTOR · Zimmer Biomet

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient is 18 to 80 years of age, inclusive
Patient is skeletally mature
Patient qualifies for unilateral total hip arthroplasty based on physical exam and medical history including at least one of the following:
Non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis
Rheumatoid arthritis
High risk for dislocation
Undergoing revision hip arthroplasty
Correction of functional deformity
In need of treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques
Patient is willing and able to complete scheduled follow-up evaluations as described in the protocol and Informed Consent
Patient, or the patient's legally authorized representative, has participated in the Informed Consent process and is willing and able to sign an IRB approved informed consent

Exclusion

Patient is septic, has an active infection or has osteomyelitis at the affected joint
Patient has significant osteoporosis as defined by treating surgeon
Patient has metabolic disorder(s) which may impair bone formation
Patient has osteomalacia
Patient has distant foci of infections which may spread to the implant site
Patient has rapid joint destruction, marked bone loss or bone resorption on pre-operative radiographs
Patient underwent contralateral THA within 3 months of planned index procedure or has a contralateral THA planned within 3 months of the index procedure
Patient is undergoing simultaneous bilateral THA
Patient has vascular insufficiency, muscular atrophy at the implant site or neuromuscular disease which might jeopardize the outcome of the surgery.
In the opinion of the investigator, patient has any concomitant disease which is likely to jeopardize the functioning or success of the implant
Patient is known to be pregnant
The patient is in the vulnerable population group, such as
a prisoner
a known alcohol or drug abuser
mentally incompetent or unable to understand what participation in this study entails

What this trial measures

  • Survival of the study device10 years

    Survival (whether or not it is still implanted in the subject) determined using Kaplan Meier method.